2026. Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring. Canadian Diabetes & Endocrinology Today. 4, 1 (May 2026), 10–16. DOI:https://doi.org/10.58931/cdet.2026.4150.